Toxicity Study and in silico ADME of some selected Anti-HIV agents inhibitors

Authors

  • S.U. Ahanonu Department of chemistry, Ahmadu University, Zaria, Nigeria
  • G.A. Shallangwa Department of chemistry, Ahmadu University, Zaria, Nigeria
  • Y.A. Dallatu Department of chemistry, Ahmadu University, Zaria, Nigeria
  • A. Ibrahim Department of chemistry, Ahmadu University, Zaria, Nigeria

Keywords:

Anti-HIV agents, Toxicity, Validation, Y- randomization

Abstract

Quantitative structural and cytotoxicity relationship (QSCR) has been carried out on twenty pyrindine-4-carboxylate derivatives using genetic function approximation combined with multiple linear regression (GFA-MLR). The following results were obtained by GFA-MLR using three descriptors AATS6i, MAT57e and TDB9s; R-squared, R2 = 0.888666, Adjusted R-squared, R2adj= 0.855266, cross validated R-squared, LOO-Q2CV = 0.710242, Y-randomization, cR2p = 0.793663 and external prediction, R2prediction = 0.8184. Their physiochemical properties are in agreement with a rule given by Lipinski’s rule and results of molecular weight ? 500 daltons, hydrogen acceptors of ? 10, hydrogen bond donors of ? 5 and octanol water partition coefficient ? 5 were obtained. This research provides an understanding on new HIV drugs with reduced toxicity and greater effectiveness.

 

References

K. Roy, J. Leonard, “QSAR modelling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congeners using molecular connectivity and t-state parameters, “Bioorg Medicinal. Chemistry, Vol.12, Issue. 4, pp. 745-754, 2004.

A.S.Ugochukwu, , G. A. Shallangwa, A. Uzairu., “Quantum and statistical study for evaluating the cytotoxicity ability of some pyrazole derivatives as potent Anti HIV-1 agents inhibitors, “International journal of New Chemistry, Vol. 8 Issue. 2, pp. 131-141, 2021.

F. Ooms, “Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry, “Current medicinal chemistry, Vol. 7 Issue. 2, pp. 141-158, 2000.

G. Liu, R. Luo, X. ZHANG, Y. ZHOU, J. LI, Y. ZHENG, H. Liu, “Synthesis and Evaluation of Anti-HIV Activities of Novel 7-Hydroxy-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-4-carboxylate Derivatives, “Medicinal chemistry, Vol.4 Issue. 8, pp. 573-580, 2014.

S.U. Ahanonu, S. U, G. A. Shallangwa, U. Adamu, “Quantitative structure and activity relationship of 3a, 6a – Dihydro-1H- pyrrolo[3,4-c] pyrazole-4,6-dione “Turkish Computational and Theoretical Chemistry, Vol. 4, Issue. 1, pp. 32 – 38, 2020.

A. Tropsha, “Best practices for QSAR model Development, Validation and Explitation, “Mol. Inf, Vol. 29, Issue. 6, pp. 476-488, 2010.

K. Roy, “Some aspects of validation of predictive quantitative structure-activity relationship models, “Expert Opinion On Drug Discovery, Vol. 2, Issue. 12, pp. 1567-1577, 2007.

S. A. Asma, A. S. Hassan, A. M. Naglah, “In vitro cytotoxicity and druglikeness of pyrazolines and pyrindines bearing benzofuran moiety, “Journal of Applied pharmaceutical science, Vol. 10, Issue. 4, pp. 142-148, 2020.

C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J.Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, “Journal of Advanced Drug Delivery. Reviews, Vol. 46 Issue. 1, pp. 3-26, 2001.

Downloads

Published

2021-10-31

How to Cite

Ahanonu, S., Shallangwa, G., Dallatu, Y., & Ibrahim, A. (2021). Toxicity Study and in silico ADME of some selected Anti-HIV agents inhibitors. International Journal of Scientific Research in Chemical Sciences, 8(5), 15–18. Retrieved from https://ijsrcs.isroset.org/index.php/j/article/view/104

Issue

Section

Research Article